314 related articles for article (PubMed ID: 25525184)
1. Whole-body PET/CT evaluation of tumor perfusion using generator-based 62Cu-ethylglyoxal bis(thiosemicarbazonato)copper(II): validation by direct comparison to 15O-water in metastatic renal cell carcinoma.
Fletcher JW; Logan TF; Eitel JA; Mathias CJ; Ng Y; Lacy JL; Hutchins GD; Green MA
J Nucl Med; 2015 Jan; 56(1):56-62. PubMed ID: 25525184
[TBL] [Abstract][Full Text] [Related]
2. Assessment of Cu-ETS as a PET radiopharmaceutical for evaluation of regional renal perfusion.
Green MA; Mathias CJ; Willis LR; Handa RK; Lacy JL; Miller MA; Hutchins GD
Nucl Med Biol; 2007 Apr; 34(3):247-55. PubMed ID: 17383574
[TBL] [Abstract][Full Text] [Related]
3. Measurement of regional cerebral blood flow with copper-62-PTSM and a three-compartment model.
Okazawa H; Yonekura Y; Fujibayashi Y; Mukai T; Nishizawa S; Magata Y; Ishizu K; Tamaki N; Konishi J
J Nucl Med; 1996 Jul; 37(7):1089-93. PubMed ID: 8965175
[TBL] [Abstract][Full Text] [Related]
4. Clinical application and quantitative evaluation of generator-produced copper-62-PTSM as a brain perfusion tracer for PET.
Okazawa H; Yonekura Y; Fujibayashi Y; Nishizawa S; Magata Y; Ishizu K; Tanaka F; Tsuchida T; Tamaki N; Konishi J
J Nucl Med; 1994 Dec; 35(12):1910-5. PubMed ID: 7989968
[TBL] [Abstract][Full Text] [Related]
5. Performance of a ⁶²Zn/⁶²Cu microgenerator in kit-based synthesis and delivery of [⁶²Cu]Cu-ETS for PET perfusion imaging.
Ng Y; Lacy JL; Fletcher JW; Green MA
Appl Radiat Isot; 2014 Sep; 91():38-43. PubMed ID: 24886964
[TBL] [Abstract][Full Text] [Related]
6. Quantitative parametric perfusion images using 15O-labeled water and a clinical PET/CT scanner: test-retest variability in lung cancer.
van der Veldt AA; Hendrikse NH; Harms HJ; Comans EF; Postmus PE; Smit EF; Lammertsma AA; Lubberink M
J Nucl Med; 2010 Nov; 51(11):1684-90. PubMed ID: 20956480
[TBL] [Abstract][Full Text] [Related]
7. Regional myocardial perfusion assessed with generator-produced copper-62-PTSM and PET.
Herrero P; Hartman JJ; Green MA; Anderson CJ; Welch MJ; Markham J; Bergmann SR
J Nucl Med; 1996 Aug; 37(8):1294-300. PubMed ID: 8708759
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a potential generator-produced PET tracer for cerebral perfusion imaging: single-pass cerebral extraction measurements and imaging with radiolabeled Cu-PTSM.
Mathias CJ; Welch MJ; Raichle ME; Mintun MA; Lich LL; McGuire AH; Zinn KR; John EK; Green MA
J Nucl Med; 1990 Mar; 31(3):351-9. PubMed ID: 2308007
[TBL] [Abstract][Full Text] [Related]
9. Multimodality functional imaging of spontaneous canine tumors using 64Cu-ATSM and 18FDG PET/CT and dynamic contrast enhanced perfusion CT.
Hansen AE; Kristensen AT; Law I; McEvoy FJ; Kjær A; Engelholm SA
Radiother Oncol; 2012 Mar; 102(3):424-8. PubMed ID: 22119225
[TBL] [Abstract][Full Text] [Related]
10. Quantification of regional myocardial perfusion with generator-produced 62Cu-PTSM and positron emission tomography.
Herrero P; Markham J; Weinheimer CJ; Anderson CJ; Welch MJ; Green MA; Bergmann SR
Circulation; 1993 Jan; 87(1):173-83. PubMed ID: 8419005
[TBL] [Abstract][Full Text] [Related]
11. In Vivo Quantitative Whole-Body Perfusion Imaging Using Radiolabeled Copper(II) Bis(Thiosemicarbazone) Complexes and Positron Emission Tomography (PET).
Green MA; Mathias CJ; Smith NJ; Cheng M; Hutchins GD
Methods Mol Biol; 2022; 2393():751-771. PubMed ID: 34837210
[TBL] [Abstract][Full Text] [Related]
12. Noninvasive parametric blood flow imaging of head and neck tumours using [15O]H2O and PET/CT.
Komar G; Oikonen V; Sipilä H; Seppänen M; Minn H
Nucl Med Commun; 2012 Nov; 33(11):1169-78. PubMed ID: 22863762
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of 62Cu-ATSM PET for evaluation of brain ischaemia and misery perfusion in patients with cerebrovascular disease.
Isozaki M; Kiyono Y; Arai Y; Kudo T; Mori T; Maruyama R; Kikuta K; Okazawa H
Eur J Nucl Med Mol Imaging; 2011 Jun; 38(6):1075-82. PubMed ID: 21287169
[TBL] [Abstract][Full Text] [Related]
14. Generator-produced copper-62-PTSM as a myocardial PET perfusion tracer compared with nitrogen-13-ammonia.
Tadamura E; Tamaki N; Okazawa H; Fujibayashi Y; Kudoh T; Yonekura Y; Magata Y; Nohara R; Sasayama S; Konishi J
J Nucl Med; 1996 May; 37(5):729-35. PubMed ID: 8965135
[TBL] [Abstract][Full Text] [Related]
15. Human biodistribution and dosimetry of the PET perfusion agent copper-62-PTSM.
Wallhaus TR; Lacy J; Whang J; Green MA; Nickles RJ; Stone CK
J Nucl Med; 1998 Nov; 39(11):1958-64. PubMed ID: 9829589
[TBL] [Abstract][Full Text] [Related]
16. Tumor blood flow measured by PET dynamic imaging of first-pass 18F-FDG uptake: a comparison with 15O-labeled water-measured blood flow.
Mullani NA; Herbst RS; O'Neil RG; Gould KL; Barron BJ; Abbruzzese JL
J Nucl Med; 2008 Apr; 49(4):517-23. PubMed ID: 18344436
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Cu-PTSM as a tracer of tumor perfusion: comparison with labeled microspheres in spontaneous canine neoplasms.
Mathias CJ; Green MA; Morrison WB; Knapp DW
Nucl Med Biol; 1994 Jan; 21(1):83-7. PubMed ID: 9234268
[TBL] [Abstract][Full Text] [Related]
18. Delineation of hypoxia in canine myocardium using PET and copper(II)-diacetyl-bis(N(4)-methylthiosemicarbazone).
Lewis JS; Herrero P; Sharp TL; Engelbach JA; Fujibayashi Y; Laforest R; Kovacs A; Gropler RJ; Welch MJ
J Nucl Med; 2002 Nov; 43(11):1557-69. PubMed ID: 12411560
[TBL] [Abstract][Full Text] [Related]
19. Species-dependent binding of copper(II) bis(thiosemicarbazone) radiopharmaceuticals to serum albumin.
Mathias CJ; Bergmann SR; Green MA
J Nucl Med; 1995 Aug; 36(8):1451-5. PubMed ID: 7629593
[TBL] [Abstract][Full Text] [Related]
20. Comparison of whole-body PET/CT and PET/MRI in breast cancer patients: lesion detection and quantitation of 18F-deoxyglucose uptake in lesions and in normal organ tissues.
Pace L; Nicolai E; Luongo A; Aiello M; Catalano OA; Soricelli A; Salvatore M
Eur J Radiol; 2014 Feb; 83(2):289-96. PubMed ID: 24331845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
